Carna Biosciences, Inc. (TYO:4572)
Japan · Delayed Price · Currency is JPY 301.00
-11.00 (-3.53%)
At close: Feb 6, 2026
Carna Biosciences Market Cap
Carna Biosciences has a market cap or net worth of 5.76 billion as of February 6, 2026. Its market cap has increased by 4.75% in one year.
Market Cap
5.76B
Enterprise Value
5.30B
Revenue
544.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
301.00
Market Cap Chart
Since March 25, 2008, Carna Biosciences's market cap has increased from 4.63B to 5.76B, an increase of 24.51%. That is a compound annual growth rate of 1.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 5.76B | -15.45% |
| Dec 30, 2025 | 6.81B | 18.93% |
| Dec 30, 2024 | 5.73B | -35.99% |
| Dec 29, 2023 | 8.95B | 21.11% |
| Dec 30, 2022 | 7.39B | -49.61% |
| Dec 30, 2021 | 14.67B | -2.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrightPath Biotherapeutics | 7.68B |
| OncoTherapy Science | 7.53B |
| Linical | 7.09B |
| PRISM BioLab Co.,LTD | 6.87B |
| TMS Co., Ltd. | 6.46B |
| Noile-Immune Biotech | 6.45B |
| Soiken Holdings | 6.43B |
| Kohjin Bio | 6.14B |